Displaying drugs 176 - 200 of 408 in total
Name | Weight | Structure | Desription | Categories |
---|---|---|---|---|
Interferon gamma-1b | 17145.6 C761H1206N214O225S6 | A form of recombinant human interferon used to treat infections associated with chronic granulomatous disease and to slow the progression of severe malignant osteopetrosis. | Interferon gamma | |
Anakinra | 17257.6 C759H1186N208O232S10 | A recombinant form of human interleukin-1 receptor antagonist used in the treatment of rheumatoid arthritis, neonatal-onset multisystem inflammatory disease and deficiency of interleukin-1 receptor antagonist (DIRA). | Interleukin Inhibitors | |
Tasonermin | 17724.0 | A tumor necrosis factor alpha used along with surgery to remove soft tissue sarcomas of the limbs. | Adjuvants, Immunologic / Antineoplastic and Immunomodulating Agents | |
Darbepoetin alfa | 18396.1 C815H1317N233O241S5 | A recombinant form of human erythropoietin used to increase differentiation of progenitor cells to red blood cells in the treatment of anemia. | Erythropoiesis-Stimulating Agents / Hematinics | |
Erythropoietin | 18396.1 C815H1317N233O241S5 | A recombinant form of human erythropoietin used to increase differentiation of progenitor cells to red blood cells in the treatment of anemia. | Colony-Stimulating Factors / Erythropoiesis-Stimulating Agents / Erythropoietin, genetics / Hematinics | |
Ancestim | 18540.0 C1662H2650N422O512S18 | A human stem cell factor used in combination with filgrastim during autologous peripheral blood progenitor cell (PBPC) transplantation to increase PBPC mobilization for improved collection. | Colony-Stimulating Factors | |
Filgrastim | 18800.0 C845H1339N223O243S9 | A form of recombinant human granulocyte colony stimulating factor used to induce the production of granulocytes and lower infection risk after myelosuppressive therapy. | Colony-Stimulating Factors | |
Oprelvekin | 19047.2 C854H1411N253O235S2 | A form of recombinant interleukin-11 used to stimulate production of megakaryocytes and platelets in patients with or at risk of thrombocytopenia after chemotherapy. | Interleukins | |
Interferon alfa-2a | 19241.1 C860H1353N227O255S9 | A form of recombinant human interferon used to stimulate the innate antiviral response in the treatment of hepatitis B and C viruses. | Interferons | |
Interferon alfa-n1 | 19241.1 C860H1353N227O255S9 | A purified form of human interferon used to stimulate the innate antiviral response in the treatment of genital warts due to human papilloma virus. | Interferons | |
Interferon alfa-2b | 19271.0 C860H1353N229O255S9 | A form of recombinant human interferon used to treat hepatitis B and C infection, genital warts, hairy cell leukemia, follicular lymphoma, malignant melanoma, and AIDs-related Kaposi's sarcoma. | Antineoplastic Agents / Antiviral Agents / Drugs causing inadvertant photosensitivity / Interferon alpha / Interferon-alpha / Interferons | |
Interferon alfacon-1 | 19343.0 C860H1353N227O255S9 | A recombinant interferon similar the interferon alfa subtype which is used to treat hepatitis C infections. | Interferons | |
Interferon beta-1b | 20011.0 C908H1408N246O253S6 | A form of recombinant human interferon used to slow the progression of relapsing multiple sclerosis and to reduce the frequency of clinical symptoms. | Interferons | |
Interferon beta-1a | 20027.0 C908H1408N246O252S7 | A form of recombinant human interferon used to slow disease progression and reduce the frequency of clinical symptoms in patients who have relapsing multiple sclerosis. | Interferons | |
Pegvisomant | 22129.0 C990H1532N262O300S7 | A growth hormone receptor antagonist used to treat acromegaly. | Acromegaly / Growth Hormone Receptor Antagonist | |
Somatotropin | 22129.0 C990H1532N262O300S7 | A recombinant human growth hormone used as replacement therapy in various conditions of growth failure, growth hormone deficiency, and weakness in children and adults. | Somatropin and Somatropin Agonists | |
Somatrem | 22255.9518 C995H1537N263O301S8 | A recombinant growth hormone used to treat adult growth hormone deficiency and treat disrupted growth in children due to growth hormone insufficiency or deficiency, turner's syndrome, chronic renal failure, and small stature for gestational age. | Somatropin and Somatropin Agonists | |
Peginterferon beta-1a | 22500.0 | An interferon beta used to treat relapsing forms of multiple sclerosis. | Interferon-beta / Interferons | |
Follitropin | 22672.9 C975H1513N267O304S26 | A form of recombinant human follicle stimulating hormone used to stimulate follicle development in women with primary ovarian hypogonadism and in men with hypogonadotropic hypogonadism. | Follicle Stimulating Hormone / Gonadotropins / Gonadotropins, Pituitary / Hormones / Thyroid Products | |
Thyrotropin alfa | 22672.9 C975H1513N267O304S26 | A recombinant form of thyroid stimulating hormone used in diagnostic testing for thyroid cancer and alongside radioactive agents to destroy thyroid tissue. | Thyroid Products | |
Anacaulase | 23000.0 | A mix of proteolytic enzymes indicated for eschar removal in adults with deep partial thickness and/or full-thickness thermal burns. | Administration, Topical / Cysteine Endopeptidases / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C9 Inhibitors / Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) / Cytochrome P-450 Enzyme Inhibitors / Enzymes / Enzymes and Coenzymes / Hydrolases / Peptide Hydrolases / Wound Healing | |
Menotropins | 23390.3 C1014H1609N287O294S27 | A purified combination of human luteinizing hormone and follicle stimulating hormone used to treat female infertility. | Biological Products / Fertility Agents, Female / Gonadotropins / Gonadotropins, Pituitary | |
Corifollitropin alfa | 25398.0389 | A FSH analogue indicated for Controlled Ovarian Stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an Assisted Reproductive Technology (ART) program. | Gonadotropins | |
Choriogonadotropin alfa | 25719.7 C1105H1770N318O336S26 | A recombinant form of human chorionic gonadotropin used to treat female infertility by inducing ovulation. | Gonadotropins | |
Brolucizumab | 26000.0 | An anti VEGF-A monoclonal antibody indicated to treat neovascular age related macular degeneration. | Antineovascularisation Agents |
Displaying drugs 176 - 200 of 408 in total